Cyclo Therapeutics, Inc.
Cyclo Therapeutics, Inc. (CYTH) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CYTH · as of Dec 31, 2024
Ownership Breakdown
21
Institutional Holders
▲ 2 vs Q3
$1.33M
Total Inst. Value
▼ $463,457 vs Q3
32.74M
Shares Outstanding
freeFloat 35.17%
2.26M
13F Shares Held
▼ 16,490 vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CYTH largest shareholders · institutional ownership
Q4 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
EPIQ CAPITAL GROUP, LLC industrial organic chemicals | 689.4K | 2.40% | 2.40% | $406.77M | Feb 7, 2025 | ▼ 50.0K |
VANGUARD GROUP INC industrial organic chemicals | 598.7K | 2.08% | 2.08% | $353.23M | Feb 11, 2025 | — held |
FOUNDERS FUND V MANAGEMENT, LLC industrial organic chemicals | 480.7K | 1.67% | 1.67% | $283.62M | Feb 14, 2025 | — held |
GEODE CAPITAL MANAGEMENT, LLC industrial organic chemicals | 152.3K | 53.02% | 53.02% | $89.91M | Feb 12, 2025 | — held |
FOUNDERS FUND VI MANAGEMENT, LLC industrial organic chemicals | 110.0K | 38.30% | 38.30% | $64.91M | Feb 14, 2025 | — held |
BLACKROCK, INC. industrial organic chemicals | 83.8K | 29.18% | 29.18% | $49.46M | Feb 7, 2025 | ▲ 301 |
TWO SIGMA SECURITIES, LLC industrial organic chemicals | 42.5K | 14.81% | 14.81% | $25.10M | Feb 14, 2025 | NEW |
STATE STREET CORP industrial organic chemicals | 39.5K | 13.76% | 13.76% | $23.32M | Feb 14, 2025 | — held |
NORTHERN TRUST CORP industrial organic chemicals | 21.7K | 7.57% | 7.57% | $12.82M | Feb 14, 2025 | ▲ 14 |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC industrial organic chemicals | 18.3K | 6.36% | 6.36% | $10.79M | Mar 17, 2025 | ▼ 5.1K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2024 vs prior quarter
Q4 2024
3
Increased
+1.6K shares4
New Positions
first time holders5
Decreased
−56.4K shares2
Sold Out
fully exitedNet shares change (top 50)
54.8K
+1.6K / −56.4K
Net new holders
+0
4 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CYTH insider trading · insider activity
Source: SEC Form 4
1
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
CONKLING WILLIAM director | Feb 27, 2025 | Award | 27,654 | — | — | 77.9K | Form 4 ↗ |
Wong Vivien director | Feb 27, 2025 | Award | 25,140 | — | — | 64.9K | Form 4 ↗ |
Cross Shawn director | Feb 27, 2025 | Award | 28,597 | — | — | 136.3K | Form 4 ↗ |
Toig Randall M. director | Feb 27, 2025 | Award | 33,311 | — | — | 179.1K | Form 4 ↗ |
STRATTAN CE RICK director | Feb 27, 2025 | Award | 30,169 | — | — | 399.3K | Form 4 ↗ |
Ostronic Francis Patrick director | Feb 27, 2025 | Award | 70,329 | — | — | 419.1K | Form 4 ↗ |
Sieger Markus director | Feb 27, 2025 | Award | 58,138 | — | — | 440.3K | Form 4 ↗ |
SHANAHAN WILLIAM S director | Feb 27, 2025 | Award | 25,140 | — | — | 174.0K | Form 4 ↗ |
Rafael Holdings, Inc. 10 percent owner | Dec 23, 2024 | C-Conversion | 3,968,254 | $0.63 | $2.50M | 13.00M | Form 4 ↗ |
CONKLING WILLIAM director | Nov 15, 2024 | Award | 16,660 | — | — | 50.2K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Cyclo Therapeutics, Inc. (CYTH) is primarily owned by institutional investors, who hold approximately 6.9% of total shares outstanding. Company insiders own approximately 64.83%, while retail and public investors account for the remaining 28.26%.
The largest institutional shareholder of Cyclo Therapeutics, Inc. is EPIQ CAPITAL GROUP, LLC, holding approximately 689,447 shares — equal to 2.40% of outstanding shares — as of December 31, 2024.
A total of 21 institutional investors currently hold CYTH stock, with a combined institutional value of approximately $1,334,477 as of the most recent 13F filing period.
Frequently asked questions
CYTH ownershipCyclo Therapeutics, Inc. (CYTH) is primarily owned by institutional investors, who hold approximately 6.9% of shares. The largest shareholder is EPIQ CAPITAL GROUP, LLC with a 2.40% stake. Company insiders hold 64.83%. Data sourced from SEC Form 13F as of December 31, 2024.